Hostetler C L, Sawyer K P, Nachamkin I
Department of Clinical Laboratory Science, School of Allied Health Science, Temple University, Philadelphia, Pennsylvania 19140.
J Clin Microbiol. 1988 Jul;26(7):1406-8. doi: 10.1128/jcm.26.7.1406-1408.1988.
Three commercial systems were compared for ability to detect antibodies to streptolysin O (ASO) and DNase B (ADB). Streptozyme (Wampole Laboratories, Cranbury, N.J.) exhibited high sensitivity (100%) for detecting ASO but low sensitivity for ADB (22.2%). The LeapStrep (Organon Teknika, Malvern, Pa.) and Check-Spectra (Diagnostic Technology, Hauppauge, N.Y.) tests had low sensitivities for detecting ASO (35.3 and 21.4%, respectively) and ADB (22.2 and 33.3%, respectively).
对三种商业系统检测抗链球菌溶血素O(ASO)和抗脱氧核糖核酸酶B(ADB)抗体的能力进行了比较。链激酶试验(新泽西州克兰伯里的万波实验室)检测ASO时表现出高灵敏度(100%),但检测ADB时灵敏度较低(22.2%)。LeapStrep试验(宾夕法尼亚州马尔文的奥加农泰克尼卡公司)和Check-Spectra试验(纽约州哈帕克的诊断技术公司)检测ASO的灵敏度较低(分别为35.3%和21.4%),检测ADB的灵敏度也较低(分别为22.2%和33.3%)。